What parameters are used to assess insulin resistance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Insulin resistance is best assessed using the hyperinsulinemic-euglycemic clamp technique, which measures the glucose disposal rate (GDR) and is considered the gold standard, although it is primarily used in research settings due to its complexity. The assessment of insulin resistance is crucial as it predicts cardiovascular morbidity and mortality in the metabolic syndrome and type 2 diabetes mellitus (T2DM) 1. In clinical practice, several parameters are used to estimate insulin resistance, including:

  • Fasting insulin levels, with elevated levels suggesting insulin resistance
  • The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), which uses fasting glucose and insulin levels in a mathematical formula to estimate insulin resistance
  • The oral glucose tolerance test (OGTT), which measures how quickly glucose is cleared from the blood after consuming a standardized amount of glucose
  • The quantitative insulin sensitivity check index (QUICKI), another calculation based on fasting glucose and insulin values
  • Additional relevant markers include glycated hemoglobin (HbA1c), triglyceride to HDL cholesterol ratio, and waist circumference, which can provide supporting evidence of insulin resistance. However, the hyperinsulinemic-euglycemic clamp technique is the most accurate method, especially in diabetes mellitus, as it directly measures insulin sensitivity by calculating the amount of glucose required to maintain normal glucose levels (euglycemia) 1. In children, the euglycemic clamp is used for research purposes only, and assessment of hyperinsulinemia by measuring fasting plasma insulin levels may provide a reasonable clinical alternative for evaluating insulin resistance 1.

From the Research

Parameters to Assess Insulin Resistance

The following parameters are used to assess insulin resistance:

  • Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) 2, 3, 4, 5, 6
  • Quantitative Insulin Sensitivity Check Index (QUICKI) 2, 3, 4, 6
  • Triglyceride-Glucose Index (TyG index) 5
  • Fasting Glucose/Insulin Ratio (FGIR) 6
  • McAuley's index 3

Calculation of Parameters

These parameters are calculated using fasting glucose and insulin levels:

  • HOMA-IR: (fasting insulin [μIU/mL] × fasting glucose [mmol/L])/22.5 5
  • QUICKI: 1/log insulin + log glycemia in mg/dL 2
  • TyG index: ln(fasting triglycerides [mg/dL] × fasting glucose [mg/dL]/2) 5
  • FGIR: fasting glucose/insulin ratio 6

Validation of Parameters

Studies have validated these parameters against other measures of insulin resistance, such as:

  • Hyperinsulinemic euglycemic clamp technique 3
  • Oral glucose tolerance test (OGTT) 6
  • Stable-labeled, frequently sampled intravenous glucose tolerance test 4

Comparison of Parameters

Comparisons between parameters have shown that:

  • HOMA-IR is more reliable than FGIR and QUICKI for assessing insulin resistance among obese children and adolescents 6
  • TyG index has a stronger association with arterial stiffness than HOMA-IR in patients with type 2 diabetes 5
  • QUICKI has better reproducibility than HOMA-IR and McAuley's index 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.